All Categories
HELPS EASE YOUR LITTLE ONE’S COLIC: Delivers clinically proven relief when managing colic due to cow’s milk allergy for a happier, better-rested baby & mom
GENTLE, FAST RELIEF: As early as the first feeding, many babies experience improvement within just 48 hours – a comforting solution for your little one
SUPERSTAR LGG PROBIOTIC: The most extensively studied probiotic for allergy management that helps support your little one’s digestive health
NOURISHING BRAIN DEVELOPMENT: Nutramigen, a gentle, lactose-free formula, has omega-3 DHA, ARA, and choline to support your baby's growing brain
IMMUNITY SUPPORT: Help your baby's immune system adapt to standard milk formula
TRUSTED BY PEDIATRICIANS*: Nutramigen is the #1 Trusted Hypoallergenic Formula Brand By Pediatricians*
SNAP ELIGIBLE: Eligible to be purchased with Supplemental Nutrition Assistance Program (SNAP) benefits
SUBSCRIBE & SAVE: Choose Subscribe and Save for additional savings and convenience
Enfamil Nutramigen Colic Baby Formula with Enflora LGG probiotics is a hypoallergenic formula proven to manage colic fast, often within 48 hours. If your baby has an allergy to the cow's milk protein in infant formula, Nutramigen contains both extensively hydrolyzed protein to provide colic relief and Enflora LGG probiotics to provide immune support to prevent allergies in the future. These two ingredients offer a more comprehensive approach working together to help babies feel better faster. The benefits of these two ingredients include: Hypoallergenic, easy to digest proteins and probiotics, proven to promote skin health in infants through 18 months of age, proven to promote digestive system health within 1 week of use, effectively manages colic in 48 hours, and promotes immune support. Nutramigen with Enflora LGG probiotics is also nutritionally balanced, lactose free, and has no added sucrose. Studied before the addition of DHA, ARA and LGG. Asthma, eczema, rhino-conjunctivitis, and urticaria at three years; in comparison to Nutramigen without LGG. ProVoice Survey fielded from January 1, 2018 to December 31, 2018 and recording recommendations for Extensively Hydrolyzed Infant Formula for cmA Patients.